In this interview, we speak with Martin Balaam, CEO and founder of Pimberly, the privately held, UK-based software as a service provider of product information management and digital asset management (DAM) solutions. Pimberly helps brands consolidate and automate complex product data workflows, becoming a deeply embedded ‘single source of truth’ across ERP, product lifestyle management and e commerce channels – driving high stickiness and low churn.

Balaam outlines the company’s expansion into the US, now representing 25% of its customer base, and discusses how Pimberly is extending its DAM capabilities to replace standalone tools typically used by digital teams. He also highlights the role of AI in automating product enrichment and preparing data for LLM driven, agent-based purchasing – an increasingly important shift, particularly in B2B. Financially, Pimberly continues to deliver strong annual recurring revenue growth, supported by targeted sector focus and expansion within existing customers. Balaam sees future opportunities for raising growth capital on public markets once conditions align.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

199. Bull, Bear & Beyond – Pimberly: executive interview

In this interview, we speak to Antti Vuolanto, CEO of Herantis Pharma, and Henri Huttunen, the company’s CSO. We discuss the latest developments for lead asset HER-096, including the Phase Ib trial readout, the supplementary biomarker programme outcomes and plans for a subsequent Phase II trial. We also cover the company’s latest fundraises as well as key upcoming potential catalysts and milestones for investors to watch out for.

Herantis Pharma is a Finland-based clinical-stage biotechnology company focused on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

198. Bull, Bear & Beyond – Herantis Pharma: executive interview

BB Biotech delivered a strong set of results in 2025, with NAV rising 26.5%, comfortably outperforming its benchmark, the Nasdaq Biotech Index. Performance was supported by a recovery in sentiment across the biotech sector and by the strength of BB Biotech’s concentrated portfolio of innovative mid-cap companies. Notably, five portfolio holdings were acquired by larger pharmaceutical groups during the year, highlighting the strategic value of the companies that BB Biotech invests in. The managers continue to focus on businesses with differentiated pipelines and clear commercial potential. Looking ahead, they expect M&A to remain an important driver of returns as large pharmaceutical companies seek exciting external drug candidates, ahead of a major patent cliff. A wide range of clinical, regulatory and commercial milestones expected across the portfolio in 2026 could provide further opportunities for value creation.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

197. Bull, Bear & Beyond – BB Biotech in 60 seconds

In our interview, Global Fashion Group’s CEO, Christoph Barchewitz, and CFO Helen Hickman discuss the FY25 results, progress made in its three geographic regions during the year, as well as the outlook for the current year and the medium term. FY25 was an important year for Global Fashion Group as the restructuring and transformation delivered an overall adjusted EBITDA profit, as well as a profit in all three regions for the first time with its current geographic exposure. Management’s expectations for further growth in profitability and lower levels of cash consumption should support a re-rating of the company’s valuation, which remains at a significant discount to its online fashion peers.

Global Fashion Group operates leading fashion and lifestyle e-commerce platforms in nine countries across three regions (Australia and New Zealand, Latin America and South-East Asia) with high growth potential. Its platforms enable global and local brands, complemented by the company’s own brands, to reach customers in markets with no capital investment.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

196. Bull, Bear & Beyond – Global Fashion Group: executive interview

In this video, we speak with Marc Desrayaud, CEO of Mikron. Marc provides an introduction to the company, outlining the operations of the two divisions, Mikron Automation and Mikron Machining Solutions. He discusses the end markets they serve, highlighting the company’s strong position in the Pharma/Medtech market, and the trends Mikron is seeing. With FY25 results recently released, he discusses the company’s record performance over the last year. He outlines Mikron’s activities in digital and lifecycle services as well as how the company is using AI to enhance its product offering and improve internal efficiency. He provides an update on the manufacturing expansion project in Switzerland and wraps up with a discussion of the outlook for the company in the coming year and in the medium term.

Mikron (SIX: MIKN) develops, produces and markets highly precise, productive and adaptable automation solutions, machining systems and cutting tools.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

195. Bull, Bear & Beyond – Mikron: executive interview

 In this episode, our director of content for investment companies, Milosz Papst talks about Partners Group Private Equity (PEY), focusing on the company’s realisations, investments and distributions to shareholders. This is our first podcast on this UK-listed investment holding company domiciled in Guernsey that provides equity capital to private companies primarily in the middle and upper-middle market. Therefore, Milosz starts with an introduction to the company and its investment manager, Partners Group, which is one of the largest firms in the global private markets industry. He then explains how PEY’s investment strategy works in practice by discussing its investment in PCI Pharma Services. Milosz comments on the transactions that contributed to the company’s more than €200m realisation proceeds received in 2025. He elaborates on the company’s dividend policy and well-structured capital allocation framework introduced in 2024, which resulted in the announcement of a €15m buyback programme in 2025. He concludes the episode by summarising PEY’s recent investment activity.

***********************************************************

About ‘Uncovering Trusts’

Uncovering Trusts': is a podcast run by Edison analysts released every two weeks. Subscribe to hear analyst interviews on how investment trusts maximise returns while managing risks for investors.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers around 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

50. Uncovering Trusts – Partners Group Private Equity (PEY): Providing balanced exposure to direct private equity investments

In this new Vantage interview, Edison's Neil Shah (managing director, market strategist) discusses with Siddarth Chand Lall, fund manager of Canaccord Wealth, the philosophy behind his multi‑cap income approach. Sid explains how disciplined balance‑sheet analysis, sustainable dividend coverage and broad sector diversification have guided the fund through every market cycle since 2011. He also shares timely views on UK valuations, sector consolidation, gold miners and where rate cuts could unlock upside across banks, property and infrastructure. For investors seeking high‑quality income with genuine breadth, this is essential viewing.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

194. Bull, Bear & Beyond – Vantage: Inside the multi-cap income opportunity – dividends, diversification and the case for UK

In this interview, we speak with Sten Sörensen, CEO of Cereno Scientific, about the key takeaways from the company’s FY25 results and recent progress across its cardiopulmonary pipeline. Sten outlines the rationale behind Cereno’s HDAC inhibition platform and its lead programmes CS1 and CS014, which target underlying disease mechanisms in pulmonary hypertension and related conditions. The discussion focuses on CS1’s upcoming Phase IIb trial in pulmonary arterial hypertension (PAH), insights expected from the expanded access programme and recent developments in the competitive landscape, including GSK’s $950m acquisition of 35Pharma (centred on its lead asset HS235) and the recent Phase III failure of seralutinib. Sten also explains the decision to expand CS014 into pulmonary hypertension associated with interstitial lung disease (PH-ILD) and provides an update on ongoing partnering discussions. He concludes by highlighting key milestones expected over the next 12–18 months, including clinical readouts and trial initiations.

Cereno Scientific (STO: CRNO-B) is a clinical-stage biotech focused on developing innovative treatments for rare diseases in the cardiovascular and pulmonary fields. Its pipeline is led by CS1 and CS014, HDAC inhibitors with disease-modifying potential in PAH and PH-ILD, respectively. Both candidates are supported by encouraging clinical data and are advancing towards later-stage clinical trials (Phase IIb for CS1 in Q226 and Phase II for CS014 in Q127). A third asset, CS585, a prostacyclin receptor agonist, is currently under preclinical evaluation for cardiovascular indications.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

193. Bull, Bear & Beyond – Cereno Scientific: executive interview

In this interview, Zalaris founder and CEO Hans-Petter Mellerud introduces the company and provides the highlights of the company’s recent FY25 results. He discusses the company’s geographic expansion plans and provides an update on progress in Asia Pacific.  He explains that he sees AI as a structural margin and competitiveness enhancer, reducing manual work, shortening implementation timelines and improving quality. While AI can improve automation, it does not eliminate the need for compliance oversight and domain expertise. Zalaris’ shared services model means it can scale its AI investments across the entire customer base, strengthening its competitive position. Finally, Hans-Petter outlines the medium-term targets for the company and explains how it expects to achieve them.

Zalaris is an Oslo-listed leading provider of comprehensive payroll and HR solutions and services that cover the entire employee lifecycle. The company operates in 18 countries across the Nordics, DACH region, the UK and Ireland and Asia-Pacific, serving over 1.5 million employees every month across all its HR solutions.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

192. Bull, Bear & Beyond – Zalaris: executive interview

In this interview, Khanh Vu, portfolio manager of VinaCapital Vietnam Opportunity Fund (VOF), and Michael Kokalari, chief economist at VinaCapital, discuss the drivers of the remarkable strength of the Vietnamese economy despite the tariff turmoil. They also provide an update on Vietnam’s progress towards an emerging market status and becoming an investment-grade country. They then comment on VOF’s positioning to benefit from these developments. They provide details of the company’s current holdings and transaction pipeline in the private equity portfolio and comment on valuations across Vietnamese equities and the fund.

VOF is a closed-end investment company that seeks to achieve medium- to long-term capital appreciation through investment in assets in Vietnam. The portfolio includes listed and unlisted equities, including private equity, covering a broad range of sectors, with a focus on Vietnamese companies that benefit from the country's rising domestic consumption and economic growth.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

191. Bull, Bear & Beyond – Vantage: Strength of the Vietnamese economy with Khanh Vu and Michael Kokalari of VinaCapital

Discover the world of investment trusts in the 'Uncovering Trusts' podcast series by Edison Group. Hear from Edison’s analysts and trusts’ management and gain insights into how these trusts, covered by Edison, effectively manage assets to maximize returns, aligning with the risk appetite and diverse requirements of both commercial and retail clients.

Edison is a leading investor relations business, operating across all major capital markets. We help create optimal valuations for client stocks, deploying our award-winning combination of intelligent strategic advice, equity research, investor marketing and direct investor engagement.

To find out more about investment trust covered by Edison, please visit: https://www.edisongroup.com/equities/investment-companies/

Uncovering Trusts by Edison Group

Edison Group's Show

Discover fresh perspectives in the Bull, Bear & Beyond podcast series by Edison Group. Our longer episodes feature candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation and the opportunities shaping their markets. These discussions offer unique insight into how leaders navigate challenges, drive growth and deliver long-term value for stakeholders. Our 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

To find out more, please visit: https://www.edisongroup.com/ [https://www.edisongroup.com/equities/investment-companies/]

Bull, Bear & Beyond by Edison Group

'Uncovering Trusts': Edison analysts interview investment trusts to uncover how they maximize returns while managing risk for clients. 

Edison Group

Shows